Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Drugs and driving.

J Michael Walsh1, Johan J de Gier, Asbjørg S Christopherson

  • 1The Walsh Group, P.A., Bethesda, Maryland, USA. jmwalsh@walshgroup.org

Traffic Injury Prevention
|July 28, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pathogen-based target attainment of optimized continuous infusion dosing regimens of piperacillin-tazobactam and meropenem in surgical ICU patients: a prospective single center observational study.

Annals of intensive care·2023
Same author

Pretomanid-resistant tuberculosis.

The Journal of infection·2023
Same author

Identification of etazene (etodesnitazene) metabolites in human urine by LC-HRMS.

Drug testing and analysis·2022
Same author

Development and evaluation of uncertainty quantifying machine learning models to predict piperacillin plasma concentrations in critically ill patients.

BMC medical informatics and decision making·2022
Same author

Analytical performance of eight enzymatic assays for ethanol in serum evaluated by data from the Belgian external quality assessment scheme.

Clinical chemistry and laboratory medicine·2022
Same author

First identification, chemical analysis and pharmacological characterization of N-piperidinyl etonitazene (etonitazepipne), a recent addition to the 2-benzylbenzimidazole opioid subclass.

Archives of toxicology·2022

Driving under the influence of drugs (DUID) poses significant risks. This overview covers drug effects on driving, toxicology, and legal challenges, recommending improved research and legislation for traffic safety.

Area of Science:

  • Public Health
  • Forensic Science
  • Traffic Safety

Background:

  • Drug-impaired driving is a global concern with significant public health and safety implications.
  • Existing research on prevalence and effects is limited by methodological challenges.
  • Understanding the scope of the problem is crucial for developing effective countermeasures.

Purpose of the Study:

  • To provide a comprehensive global overview of drugs and driving.
  • To analyze the epidemiology, effects, toxicology, and legal aspects of drug-impaired driving.
  • To identify research gaps and propose strategies for improved traffic safety.

Main Methods:

  • Review of epidemiological research on drug-impaired driving prevalence.
  • Analysis of studies on the effects of various drug classes on driving performance.

Related Experiment Videos

  • Examination of toxicological identification methods and legal frameworks (DUID laws) in the US and Europe.

    • Main Results:

    • Identified key drug classes affecting driving performance and their associated risks.
    • Highlighted methodological limitations in current epidemiological studies.
    • Discussed challenges in identifying drug users and prosecuting drugged drivers under existing laws.

    Conclusions:

    • There is a need for enhanced research to accurately define the prevalence and epidemiology of drug-impaired driving.
    • Improved toxicological testing and legal strategies, such as per se legislation, are essential for effectively managing the drugged driver problem.
    • Addressing drug-impaired driving requires a multi-faceted approach involving research, technology, and legal reform to enhance traffic safety.